MGM vs SNSE · P/E 64, rev $4.45B vs $18.6M cap
MGM Resorts International (MGM) versus Sensei Biotherapeutics Inc (SNSE) — a side-by-side from cached financials, not a winner call.
MGM Resorts International (MGM) is a resorts & casinos company listed on NYSE.
Sensei Biotherapeutics Inc (SNSE) is a biotechnology company listed on NASDAQ.
Latest reported MGM revenue for 2026-06-30 was $4.45B. Net income was $292.4M. Revenue was down 0.1% from 2026-03-31 to 2026-06-30. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
SNSE does not have a complete income-statement cache yet.
MGM currently screens at market cap $12.01B and trailing P/E 64.3. SNSE currently screens at market cap $18.6M.
Not investment advice. Open the MGM and SNSE stock pages for the full models.
Not investment advice.